• By Goodwill
  • December 14, 2023

IPO : DOMS Industries Limited

 ISSUE TYPE Book Built Issue IPO
 ISSUE OPENS ON Wednesday, December 13, 2023
 ISSUE CLOSES ON Friday, December 15, 2023
 ISSUE PRICE ₹750 to ₹790 per share
 ISSUE SIZE Up to Rs.1,200.00 Crores
 FACE VALUE Rs.10 per share

DOMS IPO is a book built issue of Rs 1,200.00 crores. The issue is a combination of fresh issue of 0.44 crore shares aggregating to Rs 350.00 crores and offer for sale of 1.08 crore shares aggregating to Rs 850.00 crores.

DOMS IPO bidding opened for subscription on December 13, 2023 and will close on December 15, 2023. The allotment for the DOMS IPO is expected to be finalized on Monday, December 18, 2023. DOMS IPO will list on BSE, NSE with tentative listing date fixed as Wednesday, December 20, 2023.

 MINIMUM BID 18 shares
 MAXIMUM BID 252 shares
 PROMOTER HOLDING 74.97% (Post-issue)
 LISTING DATE Wednesday, December 20, 2023

DOMS IPO price band is set at ₹750 to ₹790 per share. The minimum lot size for an application is 18 Shares. The minimum amount of investment required by retail investors is ₹14,220. The minimum lot size investment for sNII is 15 lots (270 shares), amounting to ₹213,300, and for bNII, it is 71 lots (1,278 shares), amounting to ₹1,009,620.

Objects of the Issue (DOMS IPO Objectives)

The net proceeds of the Fresh Issue, i.e., gross proceeds of the Fresh Issue less the offer expenses apportioned to the Company (“Net Proceeds”) are proposed to be utilised in the following manner:

1. Proposing to partly finance the cost of establishing a new manufacturing facility to expand its production capabilities for a wide range of writing instruments, watercolour pens, markers, and highlighters.

2. General corporate purposes.

SMART IPO using UPI, you can now apply online

For Existing Clients : https://gudwil.in/IPO

Open an account :  https://gudwil.in/smartFurther any clarification, feel free to contact your Branch / Relationship Manager.

For all your investment needs feel free to reach us. Give us a missed call at 90037 90027. For Support: 044-40329999Warm Regards,

Team GoodwillDISCLAIMER : Investments in the securities market are subject to market risk. Read all the related documents carefully before investing. The data and information herein provided are believed to be reliable, but Goodwill Wealth Management Pvt. Ltd., does not warrant its accuracy or completeness. Goodwill Wealth Management Pvt. Ltd., or any of its employees are not liable for any action taken by any party based on the above information. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Special note: Short-term trading on the basis of technical is high risk and skill-oriented venture and may result in huge losses also. Traders doing so are doing at their own risk. We are not responsible for any damages. Note: The material is being provided to you for educational purposes only and does not constitute investment advice; returns mentioned herein are in no way a guarantee or promise of future returns. See Disclaimer, Privacy Policy @ https://gwcindia.in/Disclaimer


  1. Fawcsd
    January 13, 2024

    strongest over the counter allergy buy zyrtec tablets best allergy medicine for itching

  2. Wmpclg
    February 3, 2024

    order generic amoxicillin 250mg amoxil 1000mg us amoxicillin 500mg generic

  3. Uqrmkf
    February 7, 2024

    prednisolone 10mg price omnacortil usa where to buy omnacortil without a prescription

  4. Jrpzxh
    February 12, 2024

    buy sildenafil 100mg sale price viagra viagra 100mg generic

  5. Qojvvi
    February 12, 2024

    purchase monodox for sale doxycycline drug doxycycline 200mg without prescription

  6. Lcvhsz
    February 13, 2024

    semaglutide 14 mg cheap rybelsus cheap purchase semaglutide generic

  7. Lixuqc
    February 14, 2024

    order lyrica 150mg without prescription lyrica brand buy lyrica generic

  8. Qyngrn
    February 27, 2024

    cheap flexeril 15mg ozobax ca buy ozobax generic

Leave a Reply

Your email address will not be published. Required fields are marked *